(Q33218266)

24 July 2017

title

Photodynamic therapy systems and applications (English)

1 reference

24 July 2017

Stuart L Marcus

1

0 references

author name string

William R McIntyre

series ordinal

2

1 reference

24 July 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Expert Opinion on Emerging Drugs

24 July 2017

published in

1 reference

24 July 2017

volume

7

1 reference

24 July 2017

issue

2

1 reference

24 July 2017

page(s)

321-334

1 reference

Aminolevulinic acid: pharmacological profile and clinical indication

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728214.7.2.321

Treating basal cell carcinoma: has photodynamic therapy come of age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.7.2.321

Long-term survival of a lung cancer patient treated with photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.7.2.321

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.7.2.321

Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.7.2.321

Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.7.2.321

Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.7.2.321

Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.7.2.321

Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.7.2.321

Photodynamic therapy in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.7.2.321

A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.7.2.321

Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.7.2.321

Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.7.2.321

Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.7.2.321

Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.7.2.321

21 January 2018

Identifiers

DOI

10.1517/14728214.7.2.321

1 reference

24 July 2017

1 reference